SBFM Q1 2020 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11,102+5289.3% YoY

Gross Profit

$7,21965.0% margin

Operating Income

-$37,699-339.6% margin

Net Income

-$94,259-849.0% margin

EPS (Diluted)

$-632.61

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

-$31,034

Free Cash Flow

-$31,034

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$63,687

Total Liabilities

$772,294

Stockholders' Equity

-$708,606

Cash & Equivalents

$10,808

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11,102	$206	+5289.3%
Gross Profit	$7,219	$34,862	-79.3%
Operating Income	-$37,699	-$122,209	+69.2%
Net Income	-$94,259	-$202,542	+53.5%